ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[Analysis and Projection of the Burden of Chronic Respiratory Diseases Attributable to Smoking in China, 1990-2021].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze trends in the disease burden of chronic respiratory diseases (CRD) attributable to smoking in China from 1990 to 2021 and to project its development from 2022 to 2035, providing scientific evidence for optimizing tobacco control strategies and public health decision-making. Methods: Using Global Burden of Disease (GBD) 2021 data, epidemiological data on smoking-attributable CRD were collected for China, Japan, the European Union, the United States, and the global population from 1990 to 2021. Indicators included years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs), covering individuals aged 30 years and older. Joinpoint regression models estimated average annual percentage changes (AAPCs), while Bayesian age-period-cohort (BAPC) models projected future trends. Results: In 2021, smoking-attributable CRD DALYs in China reached 10320279 (95% uncertainty interval [UI]: 7806610-12875089) person-years, with an age-standardized disability-adjusted life years rate (ASDR) of 522.34 (95% UI: 394.50-653.32) per 100000 person-years. The number of deaths was 566446 (95% UI: 416802-720431), with an age-standardized mortality rate (ASMR) of 31.34 (95% UI: 23.10-39.69) per 100000 population. YLLs and YLDs were 8983486 (95% UI: 6547449-11421727) person-years and 1336793 (95% UI: 981768-1699656) person-years, corresponding to age-standardized rates (ASR) of 458.96 (95% UI: 337.53-582.19) per 100000 person-years and 63.38 (95% UI: 46.17-80.72) per 100000 person-years, respectively. The disease burden showed significant differences by gender and age, with higher risks among males and middle-aged and elderly populations. From 1990 to 2021, all burden indicators in China showed a declining trend, with ASMR and ASDR projected to continue decreasing over the next decade. Conclusion: China has made positive progress in CRD prevention and tobacco control, but challenges such as population aging require continued attention. Targeted prevention interventions, particularly for high-risk populations, should be strengthened to reduce disease burden. The experience and challenges documented in China could offer valuable lessons and policy insights for other countries undergoing similar epidemiological transitions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.